30.10.2013 Views

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

European Human Genetics Conference 2007 June 16 – 19, 2007 ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Clinical genetics<br />

A 29 years old man with problem in walking and diagnosis of ataxia<br />

which was began from 5 years before with alternating dizziness, ataxia,<br />

tremor, vision disturbance and chocking.<br />

Normal mental state, cranial nerve, autonomic function, motor exam<br />

in inspection with mild hypotonia and normal sensory were seen in<br />

examination.<br />

In ophthalmologic exam all was normal but nystagmous with low speed<br />

and range.<br />

All cerebellar exam was disturbed including, ataxic gait, scanning<br />

speech, intention tremor, hyperreflexia, dysphagia, dysmetria and dysdiadokinesis.<br />

Brain MRI was normal.<br />

There was history of such a problem in his mother, his mother’s 3<br />

sibling and also grandfather which was presented in higher age and in<br />

their children in lower age.<br />

Case 2:<br />

A 36 years old man with progressive ataxia and tremor which was began<br />

from 6 years before with one apparently normal child, normal mental<br />

state, disturbed cerebellar exam including progressive ataxic gait,<br />

dysartheria, intention and postural tremor, dysmetria, dysdiadokinesis<br />

was seen in exam. Brain MRI showed cerebellar atrophy.<br />

There was some history of such a problem in his father, sib line and<br />

also in pedigree<br />

Diagnosis:<br />

Extracted DNA was investigated for the GAA expansion repeat in the<br />

FRDA gene and SCA types including 1,2,3,6,7.<br />

The two probands showed abnormal pattern for SCA 7 and SCA 2<br />

respectively.<br />

P0236. Juvenile and young adults SCA1 patients in Poland -<br />

genetic and clinical features.<br />

E. Zdzienicka, M. Rakowicz, R. Rola, A. Sulek-Piatkowska, T. Jakubowska, W.<br />

Szirkowiec, R. Poniatowska, U. Zalewska, J. Zaremba, E. Bertrand;<br />

Institute of Psychiatry and Neurology, Warsaw, Poland.<br />

Spinocerebellar ataxia type 1 (SCA1) is the most common form of<br />

ADCA in Poland. The phenotype and age at disease onset are highly<br />

variable. The aim of the study was to investigate the influence of the<br />

transmission pattern on genetic and clinical features of juvenile SCA1<br />

patients.<br />

Methods: 125 SCA1 patients from 101 families were analysed retrospectively.<br />

The mean age at onset was 35.6 +/- 9.6 and the average<br />

CAG repeats in affected family members was 50.7 +/- 5.5, ranging<br />

from 42 to 72. Paternal and maternal transmission was equal. In 21<br />

SCA1 families with 25 juvenile patients, the relation of clinical severity,<br />

sex, CAG repeats number and age at disease onset of transmitting<br />

parents was analysed. The International Cooperative Ataxia Rating<br />

Scale (ICARS), electrophysiological and psychological examinations<br />

were compared in regard to transmission pattern.<br />

Results: In 14 cases with paternal and in 11 patients with maternal<br />

transmission the mean age at onset 20.5 +/-3.6 y. (range 12 - 25 y.),<br />

disease duration 6.3 +/-3.7 y. and the CAG repeats number, mean<br />

58.0 +/- 5.7 were not different. However, mean age at onset of fathers<br />

was 33.0 y. and of mothers 29.1y. Severity of non-cerebellar signs and<br />

ataxia were more pronounced in patients with paternal than with maternal<br />

transmission: ICARS 34.8 and 32.8, Intelligence Quotient 92.9<br />

and 107, respectively.<br />

Conclusions: In our SCA1 patients the anticipation was more prominent<br />

in subjects with paternal than with maternal transmission.<br />

Supported by Polish Ministry of Science grant 3PO5B 0<strong>19</strong> 24, partly by<br />

EUROSCA/LSHM-CT-2004-503304.<br />

P0237. A case of spinocerebellar ataxia type 17 (SCA17)<br />

associated with homozygous 46/47 repeats of the TBP gene<br />

P. Tarantino1 , E. V. De Marco1 , E. Pisano2 , F. Annesi1 , F. E. Rocca1 , D. Civitelli1 ,<br />

I. C. Cirò Candiano1 , S. Carrideo1 , G. Provenzano1 , V. Greco1 , G. Squillace1 , M.<br />

Caracciolo1 , G. Annesi1 ;<br />

1 2 Institute of Neurological Sciences, Mangone (Cosenza), Italy, Department of<br />

Neurology Hospital Cosenza, Cosenza, Italy.<br />

Spinocerebellar ataxia type 17 (SCA17) is a dominant progressive<br />

neurodegenerative disorder, caused by a triplet repeat expansion<br />

within the TATA-binding protein gene (TBP); normal expansions range<br />

from 29 to 42 repeats, whereas abnormal expansions range from 43<br />

to 63 repeats. A reduced penetrance is associated to 43-48 repeats.<br />

The disease is characterized by progressive limb and gait ataxia, dys-<br />

arthria, motor, cognitive and psychiatric abnormalities.<br />

In this study, we describe a SCA patient from Southern Italy with ataxia,<br />

pyramidal and extrapyramidal signs and peripheral neuropathy.<br />

We investigated this patient for CAG repeat expansions in the genes of<br />

the spinocerebellar ataxias SCA1, SCA2, SCA3 SCA6, SCA7, SCA8,<br />

SCA12, SCA17 and DRPLA.<br />

Genomic DNA was amplified with fluorescent primers spanning the<br />

SCA expansions. PCR products were separated onto a capillary sequencer<br />

(3130XL genetic analyzer-Applied Biosystems) and the length<br />

of specific SCA fragments was calculated referring to a size standard<br />

and to related SCA controls. We identified an abnormal CAG/CAA repeat<br />

expansion of 46/47 size, within the TBP gene, confirmed by direct<br />

sequencing of the expanded SCA17 alleles showing the following structure:<br />

(CAG)3 (CAA)3(CAG)9CAACAGCAA(CAG)26/27CAACAG.<br />

This is the second case of homozygous expansion reported in a patient<br />

with SCA17. Currently, genetic and clinical analysis of other family<br />

members are ongoing to evaluate the genotype-phenotype correlation<br />

in this family.<br />

P0238. Identification of genomic dosage variation of CNTNAP2<br />

in patients with schizophrenia and epilepsy<br />

T. Vrijenhoek;<br />

Radboud University Medical Centre Nijmegen, Nijmegen, The Netherlands.<br />

Contactin-associated protein-like 2 (Caspr2) clusters voltage-gated<br />

potassium channels (K v1.1) at the nodes of Ranvier and is encoded<br />

by CNTNAP2 - the largest gene in the human genome. Homozygous<br />

stop mutations in exon 22 of this gene were recently identified in Old<br />

Order Amish children with cortical dysplasia, focal epilepsy, relative<br />

macrocephaly, and diminished deep-tendon reflexes. We identified<br />

deletions affecting (part of) CNTNAP2 in three patients by routine<br />

chromosome analysis and microarray-based genomic copy number<br />

analysis methods.<br />

A deletion covering the chromosomal region 7q34-7q36.1 was revealed<br />

in one severely mentally retarded epilepsy patient by routine<br />

chromosome analysis, and shown to be de novo by Fluorescent In-<br />

Situ Hybridisation (FISH) analysis. The deletion was 10.7 Mb in size,<br />

affecting 58 genes including CNTNAP2. A second deletion was identified<br />

by array-based Comparative Genomic Hybridisation (arrayCGH)<br />

in a patient suffering from both epilepsy and schizophrenia. This deletion<br />

of 1.5 Mb was confirmed by Multiplex Logation-dependent Probe<br />

Amplification (MLPA), and also affected CNTNAP2. To study the link<br />

between schizophrenia and CNTNAP2 further, we developed a targeted<br />

Single Nucleotide Polymorphism (SNP) array for this gene and its<br />

surrounding genomic region. Out of 315 patients and an equal number<br />

of controls, we identified a deletion in intron 3 of CNTNAP2 in a third<br />

schizophrenic patient, which also has a history of epilepsy.<br />

Together these results confirm that CNTNAP2 is associated with epilepsy,<br />

but they also show that genomic rearrangements resulting in<br />

haploinsufficiency of CNTNAP2 may lead to a more complex phenotype<br />

that also includes schizophrenia.<br />

P0239. A Case of Seckel Syndrome conceived by Assisted<br />

Reproductive Technology<br />

N. Andıran1 , E. Tuncbilek2 , E. Odemıs1 , D. Aktas2 ;<br />

1 2 Fatih University, Department of Pediatrics, Ankara, Turkey, Hacettepe University<br />

School of Medicine, Department of <strong>Genetics</strong>, Ankara, Turkey.<br />

Seckel syndrome is a rare autosomal recessive disorder characterized<br />

by severe pre- and postnatal growth retardation, microcephaly, mental<br />

retardation and typical facial appearance. It has also been called “birdheaded<br />

dwarfism”. Related with Seckel syndrome, three loci have been<br />

mapped and to date the only causative mutation has been observed<br />

as a hypomorphic mutation in Ataxia telengiectasia and Rad3-related<br />

(ATR) gene. Although assisted reproductive technologies (ART) including<br />

in vitro fertilization (IVF) and intracytoplasmic sperm injection<br />

(ICSI) are generally considered safe, some studies have suggested an<br />

excess occurrence of birth defects and low birth-weight. Recently, various<br />

syndromes involving epigenetic alterations have been reported to<br />

occur in individuals following ART. Here we report a patient with Seckel<br />

Syndrome conceived by ICSI. To the best of our knowledge, Seckel<br />

syndrome has not been reported in patients conceived by ART and we<br />

think that epigenetic mechanisms may be related with this syndrome<br />

in our patient.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!